ReviewFrontiers in immunology2026

Advancing osteosarcoma treatment: the impact of intratumoral metabolic reprogramming on immunotherapy.

Jiawei Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.